BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30618047)

  • 1. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome.
    Drake J; Schreiber KC; Lopez R; Fasaye GA; Connolly M; Quezado M; Heller T; Hernandez JM; Davis JL
    J Surg Oncol; 2019 May; 119(6):673-674. PubMed ID: 30618047
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy?
    Sánchez Fuentes PA; Vidaña Márquez E; Velasco Albendea FJ
    Med Clin (Barc); 2021 Jul; 157(1):46-48. PubMed ID: 32773164
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1-related blepharocheilodontic syndrome is associated with diffuse gastric cancer risk.
    LeBlanc S; Naveen D; Haan E; Barnett C; Rawlings L; Roscioli T; Poplawski N
    Am J Med Genet A; 2020 Jul; 182(7):1780-1784. PubMed ID: 32302040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
    Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
    Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive resection of hereditary diffuse gastric cancer].
    Hoogerbrugge N; Ligtenberg MJ; Nagengast FM; Bonenkamp JJ; van Krieken JH
    Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2417-20. PubMed ID: 17131699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
    Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.
    Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M
    Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family.
    Niemeyer E; Mofid H; Zornig C; Burandt EC; Stein A; Block A; Volk AE
    BMC Gastroenterol; 2020 May; 20(1):129. PubMed ID: 32362280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary gastric cancer: what's new? Update 2013-2018.
    van der Post RS; Oliveira C; Guilford P; Carneiro F
    Fam Cancer; 2019 Jul; 18(3):363-367. PubMed ID: 30989426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
    DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
    J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
    Gamble LA; Heller T; Davis JL
    JAMA Surg; 2021 Apr; 156(4):387-392. PubMed ID: 33404644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?
    Ziogas D; Roukos DH
    Ann Surg Oncol; 2009 Oct; 16(10):2678-81. PubMed ID: 19636637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
    Svrcek M
    Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic background and clinical features of hereditary diffuse gastric cancer].
    Vasas P; Bijendra P
    Orv Hetil; 2011 Jul; 152(28):1105-9. PubMed ID: 21737393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
    Zhang Q; Yang Z; Karamchandani DM
    Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations of the E-cadherin gene (CDH1) in early onset gastric cancer.
    Corso G; Roviello F
    Semin Oncol; 2020; 47(2-3):125-126. PubMed ID: 32416945
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies and strengths in prophylactic total gastrectomy for germline CDH1 pathogenic variant carriers.
    Davis JL; Strong VE
    Eur J Cancer Prev; 2023 Jul; 32(4):308-309. PubMed ID: 37038999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.